Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05643976 · ClinicalTrials.gov registry record · NA
Investigating KardioPAC Mobile App to Improve Physical Fitness Among Cardiac Rehabilitation Patients
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT05643976: Completed NA study, sponsored by University of California, San Diego.
NCT05643976 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05643976, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to sustain regular physical activity, improve health-related quality of life, improve resting blood pressure, improve anthropometrics, and improve adherence to prescribed cardiac rehabilitation sessions among individuals referred for cardiac rehabilitation (CR). Numerous studies show that CR improves clinical outcomes in cardiovascular disease (CVD). Exercise as a reliable adjunctive intervention, however, remains limited due to poor short- and long-term adherence. This proposed study will examine the effectiveness of the Kura Care KardioPac digital application plus CR to significantly sustain exercise adherence among CR patients, as compared to standard of care alone.
Primary Outcome
Assess the ability of CR + KardioPAC as compared to standard-of-care CR to change the activity level of participants.
Interventions
- OTHER Standard of Care
- BEHAVIORAL KardioPAC Mobile Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2023-01-18 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
What the finished NCT05643976 record still lists
NCT05643976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05643976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05643976 about?
NCT05643976 is a clinical study titled "Investigating KardioPAC Mobile App to Improve Physical Fitness Among Cardiac Rehabilitation Patients". The purpose of this study is to sustain regular physical activity, improve health-related quality of life, improve resting blood pressure, improve anthropometrics, and improve adherence to prescribed cardiac rehabilitation sessions among individuals referred for cardiac rehabilitation (CR). Numerous...
What is the current status of trial NCT05643976?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2023-01-18. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT05643976?
The interventions under investigation include: Standard of Care (OTHER), KardioPAC Mobile Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT05643976?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05643976's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI